Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-03 5:44 pm Purchase |
2024-03-25 | 13G | Bio-Path Holdings, Inc. BPTH |
Mitchell P. Kopin | 53,700 7.100% |
53,700 (New Position) |
Filing History |
| 2024-03-21 4:42 pm Purchase |
2024-03-12 | 13G | ASLAN Pharmaceuticals Limited ASLN |
Mitchell P. Kopin | 3,125,000 4.400% |
3,125,000 (New Position) |
Filing History |
| 2024-03-14 5:10 pm Purchase |
2024-03-04 | 13G | Bone Biologics Corporation BBLG |
Mitchell P. Kopin | 99,605 9.990% |
99,605 (New Position) |
Filing History |
| 2024-03-06 4:09 pm Purchase |
2024-02-26 | 13G | Aclarion, Inc. ACON |
Mitchell P. Kopin | 38 4.990% |
38 (New Position) |
Filing History |
| 2024-03-01 4:28 pm Purchase |
2024-02-22 | 13G | Venus Concept Inc. VERO |
Mitchell P. Kopin | 29,160 4.990% |
29,160 (New Position) |
Filing History |
| 2024-02-12 06:16 am Purchase |
2024-02-02 | 13G | Nuvve Holding Corp. NVVE |
Mitchell P. Kopin | 41,100 8.900% |
41,100 (New Position) |
Filing History |
| 2024-02-06 11:12 am Purchase |
2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 814,383 1.800% |
787,291 (+2905.99%) |
Filing History |
| 2024-02-06 10:30 am Purchase |
2023-12-31 | 13G | OceanPal Inc. OP |
Mitchell P. Kopin | 105,655 1.400% |
105,655 (New Position) |
Filing History |
| 2024-02-06 10:30 am Purchase |
2023-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 99,045 9.990% |
99,045 (New Position) |
Filing History |
| 2024-02-06 10:29 am Purchase |
2023-12-31 | 13G | Palisade Bio, Inc. PALI |
Mitchell P. Kopin | 12,035 1.900% |
3,296 (+37.72%) |
Filing History |
| 2024-02-06 10:27 am Sale |
2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 13,012 1.500% |
-6,185 (-32.22%) |
Filing History |
| 2024-02-06 10:24 am Unchanged |
2023-12-31 | 13G | NAYA Biosciences, Inc. NAYA |
Mitchell P. Kopin | 15,333 6.900% |
0 (Unchanged) |
Filing History |
| 2024-02-06 10:24 am Purchase |
2023-12-31 | 13G | Performance Shipping Inc. PSHG |
Mitchell P. Kopin | 472,800 3.900% |
206,134 (+77.30%) |
Filing History |
| 2024-02-06 10:23 am Sale |
2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 6,191 6.600% |
-495 (-7.40%) |
Filing History |
| 2024-02-06 10:22 am Purchase |
2023-12-31 | 13G | Helius Medical Technologies, Inc. HSDT |
Mitchell P. Kopin | 39 0.100% |
39 (New Position) |
Filing History |
| 2024-02-06 10:19 am Purchase |
2023-12-31 | 13G | Guardion Health Sciences, Inc. GHSI |
Mitchell P. Kopin | 50,000 3.800% |
50,000 (New Position) |
Filing History |
| 2024-02-06 10:17 am Sale |
2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
Mitchell P. Kopin | 644 6.200% |
-272 (-29.66%) |
Filing History |
| 2024-02-06 10:16 am Purchase |
2023-12-31 | 13G | Synaptogenix, Inc. SNPX |
Mitchell P. Kopin | 41,929 4.990% |
10,460 (+33.24%) |
Filing History |
| 2024-02-06 10:14 am Purchase |
2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Mitchell P. Kopin | 23,961 0.900% |
23,961 (New Position) |
Filing History |
| 2024-02-06 10:12 am Unchanged |
2023-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 53,667 8.100% |
0 (Unchanged) |
Filing History |